Misspliced GSK3beta mutants stabilize beta-catenin levels

Stable Identifier
R-HSA-5339713
Type
Reaction [transition]
Species
Homo sapiens
Compartment
cytosol
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Misspliced GSK3beta mutants stabilize beta-catenin levels
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

GSK3beta mRNA is subject to aberrant splicing in stem cells in chronic myeloid leukemia. Missplicing leads to in-frame deletion of exons 8 and 9 which encode the FRAT and AXIN binding domains of the protein (Jamieson et al, 2008; Abrahamsson et al, 2009). Cells expressing the mutant GSK3beta have elevated levels of nuclear beta-catenin and high levels of TCF-dependent reporter activity (Jamieson et al, 2008; Abrahamsson et al, 2009). Although it is possible that the defect in the ability of mutant GSK3beta to promote beta-catenin degradation arises from an inability to bind to AXIN and form a functional degradation complex, this has not been formally demonstrated.

Literature References
PubMed ID Title Journal Year
19237556 Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation

Abrahamsson, AE, Geron, I, Gotlib, J, Dao, KH, Barroga, CF, Newton, IG, Giles, FJ, Durocher, J, Creusot, RS, Karimi, M, Jones, C, Zehnder, JL, Keating, A, Negrin, RS, Weissman, IL, Jamieson, CH

Proc. Natl. Acad. Sci. U.S.A. 2009
15306667 Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

Jamieson, CH, Ailles, LE, Dylla, SJ, Muijtjens, M, Jones, C, Zehnder, JL, Gotlib, J, Li, K, Manz, MG, Keating, A, Sawyers, CL, Weissman, IL

N. Engl. J. Med. 2004
Participants
Input
Participant Of
hasEvent
Normal reaction
Phosphorylation of phospho-(Ser45 ) at Thr 41 by GSK-3 (Homo sapiens)
Disease
Name Identifier Synonyms
chronic myeloid leukemia 8552 CML, chronic myelogenous leukemia, no ICD-O subtype (morphologic abnormality), chronic myeloid leukemia, disease (disorder), chronic myeloid leukemia without mention of remission, CML - chronic Myelogenous Leukemia, chronic myeloid leukemia in remission (disorder), Myeloid Leukemia, chronic, CML in Remission, chronic myeloid leukemia in remission, chronic myeloid leukaemia, chronic myeloid leukemia NOS (disorder)
Authored
Rothfels, K  (2014-02-22)
Reviewed
Salahshor, S  (2014-05-12)
Woodgett, J  (2014-05-22)
Created
Rothfels, K  (2014-03-08)
Cite Us!